reported Wednesday.” data-reactid=”19″>The United States Centers for Disease Control and Prevention notified public health authorities in all 50 states and five large cities to begin preparations to distribute two unidentified vaccines in late October or early November, the New York Times reported Wednesday.
The agency has reportedly spelled out technical specifications for both vaccines including requirements for their shipping, mixing, storage and administration.
PFE) and Moderna Inc (NASDAQ: MRNA), which are in advanced clinical trials, as per the Times.
The scenarios reportedly assume that the two vaccines will be deemed safe and effective enough to receive an emergency authorization from the Food and Drug Administration by the end of October.
guidelines, in the form of three documents, were sent out to officials in all states and five cities on Aug. 27— the same day President Donald Trump announced at the Republican National Convention that a vaccine may be available before the end of 2020, the Times noted.” data-reactid=”28″>Why It Matters: The CDC guidelines, in the form of three documents, were sent out to officials in all states and five cities on Aug. 27— the same day President Donald Trump announced at the Republican National Convention that a vaccine may be available before the end of 2020, the Times noted.
Vaccine A, which may be Pfizer’s product is likely to have 2 million doses ready by October and Vaccine B, the one most likely made by Moderna, would have one million doses ready by that period, according to the documents.
The documents state that tens of millions of doses would be ready by the end of the year.
JNJ), Pfizer and its partner BioNTech SE (NASDAQ: BNTX), AstraZeneca Plc (NYSE: AZN), and Sanofi SA (NASDAQ: SNY) along with GlaxoSmithKline plc (NYSE: GSK) have deals in place to supply vaccines to the government.
View Article Origin Here
